Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | 0.00% | 0.00% | 0.00% |
Valuation
Fiscal Period: March | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Capitalization 1 | 79.37 | 18.51 | 11 | 6.028 | 4.525 | 2.093 |
Enterprise Value (EV) 1 | 79.57 | 19.05 | 11.85 | 7.488 | 6.113 | 3.689 |
P/E ratio | -18.5 x | -4.44 x | -4.33 x | -1.59 x | -0.9 x | -0.53 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | - | - | - | - | - | - |
EV / Revenue | - | - | - | - | - | - |
EV / EBITDA | -28.7 x | -7.2 x | -6.89 x | -4.02 x | -2.69 x | -2.29 x |
EV / FCF | 2,966 x | -48.8 x | -14.9 x | -7.78 x | -4.89 x | -8.15 x |
FCF Yield | 0.03% | -2.05% | -6.73% | -12.9% | -20.4% | -12.3% |
Price to Book | 122 x | 63.2 x | -27.1 x | -3.89 x | -3.04 x | -1.19 x |
Nbr of stocks (in thousands) | 32,265 | 37,628 | 49,113 | 79,317 | 176,058 | 402,474 |
Reference price 2 | 2.460 | 0.4920 | 0.2240 | 0.0760 | 0.0257 | 0.005200 |
Announcement Date | 7/14/17 | 7/16/18 | 7/10/19 | 8/14/20 | 7/1/21 | 7/27/22 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales | - | - | - | - | - | - |
EBITDA 1 | -2.772 | -2.644 | -1.719 | -1.861 | -2.274 | -1.612 |
EBIT 1 | -2.999 | -2.975 | -1.975 | -2.03 | -2.36 | -1.683 |
Operating Margin | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -3.807 | -3.91 | -2.273 | -3.218 | -3.332 | -2.581 |
Net income 1 | -3.807 | -3.91 | -2.273 | -3.218 | -3.332 | -2.581 |
Net margin | - | - | - | - | - | - |
EPS 2 | -0.1331 | -0.1108 | -0.0517 | -0.0478 | -0.0285 | -0.009856 |
Free Cash Flow 1 | 0.0268 | -0.3899 | -0.7979 | -0.9626 | -1.25 | -0.4524 |
FCF margin | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 7/14/17 | 7/16/18 | 7/10/19 | 8/14/20 | 7/1/21 | 7/27/22 |
Balance Sheet Analysis
Fiscal Period: March | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net Debt 1 | 0.19 | 0.54 | 0.85 | 1.46 | 1.59 | 1.6 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | -0.07 x | -0.2025 x | -0.4947 x | -0.7844 x | -0.6987 x | -0.9896 x |
Free Cash Flow 1 | 0.03 | -0.39 | -0.8 | -0.96 | -1.25 | -0.45 |
ROE (net income / shareholders' equity) | -752% | -801% | 3,992% | 326% | 218% | 159% |
ROA (Net income/ Total Assets) | -142% | -134% | -89.8% | -103% | -125% | -96.1% |
Assets 1 | 2.689 | 2.926 | 2.531 | 3.137 | 2.662 | 2.687 |
Book Value Per Share 2 | 0.0200 | 0.0100 | -0.0100 | -0.0200 | -0.0100 | -0 |
Cash Flow per Share 2 | 0 | 0 | 0 | 0 | 0 | 0 |
Capex 1 | 0.12 | 0.11 | 0.11 | 0.04 | 0.05 | - |
Capex / Sales | - | - | - | - | - | - |
Announcement Date | 7/14/17 | 7/16/18 | 7/10/19 | 8/14/20 | 7/1/21 | 7/27/22 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
0.00% | 153K | |
-14.64% | 143B | |
-6.33% | 118B | |
-0.93% | 72.22B | |
+4.22% | 50.88B | |
+15.88% | 48.79B | |
+33.66% | 41.86B | |
+22.26% | 26.52B | |
+34.23% | 21.47B | |
+49.46% | 18.94B |
- Stock Market
- Equities
- MXSG Stock
- Financials Mexus Gold US